Table: Aska Pharmaceutical - 9-MTH group results

ASKA Pharmaceutical Holdings

03/02/2020 06:00

Feb 3 (Reuters)- 
             Aska Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             41.21               37.02            53.00    
                 (+11.3 pct)         (-4.4 pct)       (+13.5 pct) 
  Operating          1.52                2.58             2.00    
                 (-41.0 pct)         (-25.5 pct)      (+12.2 pct) 
  Recurring          1.73                2.80             2.10    
                 (-38.2 pct)         (-24.1 pct)      (+6.1 pct)  
  Net                1.06                2.22             1.00    
                 (-52.0 pct)         (-26.8 pct)      (-42.7 pct) 
  EPS             37.66 yen           78.55 yen        35.41 yen  
  Ann Div                             14.00 yen        14.00 yen  
  -Q2 div         7.00 yen            7.00 yen                    
  -Q4 div                             7.00 yen         7.00 yen   
  
  NOTE - Aska Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T